The Effect of Ursolic Acid from Plantago Lanceolata Leaves on Leukocytes Migration and Chemokines Level

Nanang Fakhrudin; Yuvianti Dwi Franyoto; Eny Dwi Astuti; Arief Nurrochmad; Subagus Wahyuono

doi:10.14499/indonesianjpharm30iss4pp252

The Effect of Ursolic Acid from Plantago Lanceolata Leaves on Leukocytes Migration and Chemokines Level

Nanang Fakhrudin, Yuvianti Dwi Franyoto, Eny Dwi Astuti, Arief Nurrochmad, Subagus Wahyuono

Abstract

Initially considered as a normal body response to injury, inflammation is currently known as a major event contributing to the development of many human disorders. Many drugs and bioactive molecules have been discovered from medicinal plants and the number is still growing by time. Among those medicinal plants used in folk medicines, Plantago lanceolata is used to cure inflammatory-related diseases. In our previous study, we showed that the n-hexane insoluble fraction of P. lanceolata leaves (HIF) demonstrated a potent anti-inflammatory activity by inhibiting leukocytes migration in mice. This study aimed to identify the anti-inflammatory compound from the HIF and to investigate the effect on the chemokines level. P. lanceolata leaves were initially macerated with dichloromethane. The dried extract was partitioned using n-hexane to obtain n-hexane soluble fraction (HSF) and n-hexane insoluble fraction (HIF). Both fractions were evaluated for their anti-inflammatory activities in thioglycollate-induced leukocyte migration. The active fraction (HIF) was subjected to preparative thin-layer chromatography (TLC) to isolate the major compound. The structure of the compound was identified based on NMR, IR, and Mass spectra. Moreover, we investigated the effect of the compound on the level of chemokines responsible for leukocytes migration. The active compound was identified as ursolic acid, based on its spectral data. Ursolic acid at the dose of 30, 60, and 120mg/kg BW inhibited leukocyte migration and reduced chemokines level (IL-8 and MCP-1).

Keywords

plantago, anti-inflammatory agents, leukocyte, chemokine CCL2, interleukin-8

Full Text:

PDF

References

Balamayooran, G., Batra, S., Balamayooran, T., Cai, S., & Jeyaseelan, S. 2011. Monocyte chemoattractant protein 1 regulates pulmonary host defense via neutrophil recruitment during Escherichia coli infection. Infect Immun, 79(7), 2567-2577. doi:10.1128/iai.00067-11

Baumgartner, L., Sosa, S., Atanasov, A. G., Bodensieck, A., Fakhrudin, N., Bauer, J., Favero, G. D., Ponti, C., Heiss, E. H., Schwaiger, S., Ladurner, A., Widowitz, U., Loggia, R. D., Rollinger, J. M., Werz, O., Bauer, R., Dirsch, V. M., Tubaro, A., & Stuppner, H. 2011. Lignan Derivatives from Krameria lappacea Roots Inhibit Acute Inflammation in Vivo and Pro-inflammatory Mediators in Vitro. Journal of Natural Products, 74(8), 1779-1786. doi:10.1021/np200343t

Cash, J. L., White, G. E., & Greaves, D. R. 2009. Chapter 17. Zymosan-induced peritonitis as a simple experimental system for the study of inflammation. Methods Enzymol, 461, 379-396. doi:10.1016/s0076-6879(09)05417-2

Chang, G. T., Kang, S. K., Kim, J. H., Chung, K. H., Chang, Y. C., & Kim, C. H. 2005. Inhibitory effect of the Korean herbal medicine, Dae-Jo-Whan, on platelet-activating factor-induced platelet aggregation. J Ethnopharmacol, 102(3), 430-439. doi:10.1016/j.jep.2005.07.003

Charo, I. F., & Taubman, M. B. 2004. Chemokines in the pathogenesis of vascular disease. Circ Res, 95(9), 858-866. doi:10.1161/01.res.0000146672.10582.17

Chavakis, T., Athanasopoulos, A., Rhee, J. S., Orlova, V., Schmidt-Woll, T., Bierhaus, A., May, A. E., Celik, I., Nawroth, P. P., & Preissner, K. T. 2005. Angiostatin is a novel anti-inflammatory factor by inhibiting leukocyte recruitment. Blood, 105(3), 1036-1043. doi:10.1182/blood-2004-01-0166

Checker, R., Sandur, S. K., Sharma, D., Patwardhan, R. S., Jayakumar, S., Kohli, V., Sethi, G., Aggarwal, B. B., & Sainis, K. B. 2012. Potent Anti-Inflammatory Activity of Ursolic Acid, a Triterpenoid Antioxidant, Is Mediated through Suppression of NF-κB, AP-1 and NF-AT. PLoS One, 7(2), 1-15. doi:10.1371/journal.pone.0031318

Dawid-Pać, R. 2013. Medicinal plants used in treatment of inflammatory skin diseases. Advances in Dermatology and Allergology/Postȩpy Dermatologii I Alergologii, 30(3), 170-177. doi:10.5114/pdia.2013.35620

Del Prete, A., Sozzani, S., Bonecchi, R., & Locati, M. 2015. Chemokines as effector and target molecules in vascular biology. Cardiovascular Research, 107(3), 364-372. doi:10.1093/cvr/cvv150 %J Cardiovascular Research

Ellingsen, T., Elling, P., Olson, A., Elling, H., Baandrup, U., Matsushima, K., Deleuran, B., & Stengaard-Pedersen, K. 2000. Monocyte chemoattractant protein 1 (MCP-1) in temporal arteritis and polymyalgia rheumatica. Ann Rheum Dis, 59(10), 775-780.

Epstein, S. P., Ahdoot, M., Marcus, E., & Asbell, P. A. 2009. Comparative toxicity of preservatives on immortalized corneal and conjunctival epithelial cells. Journal of ocular pharmacology and therapeutics: the official journal of the Association for Ocular Pharmacology and Therapeutics, 25, 113-119. doi:10.1089/jop.2008.0098

Fakhrudin, N., Dwi Astuti, E., Sulistyawati, R., Santosa, D., Susandarini, R., Nurrochmad, A., & Wahyuono, S. 2017. n-Hexane Insoluble Fraction of Plantago lanceolata Exerts Anti-Inflammatory Activity in Mice by Inhibiting Cyclooxygenase-2 and Reducing Chemokines Levels. Sci Pharm, 85(1), 1-12. doi:10.3390/scipharm85010012

Fakhrudin, N., Waltenberger, B., Cabaravdic, M., Atanasov, A. G., Malainer, C., Schachner, D., Heiss, E. H., Liu, R., Noha, S. M., Grzywacz, A. M., Mihaly-Bison, J., Awad, E. M., Schuster, D., Breuss, J. M., Rollinger, J. M., Bochkov, V., Stuppner, H., & Dirsch, V. M. 2014. Identification of plumericin as a potent new inhibitor of the NF-kappaB pathway with anti-inflammatory activity in vitro and in vivo. Br J Pharmacol, 171(7), 1676-1686. doi:10.1111/bph.12558

Geană, E.-I., Ionete, R. E., Ciocarlan, A., Aricu, A., Fulga, A., Ungur, N., Podogova, M., & Nikolaeva, D. 2014. Hplc determination of oleanolic and ursolic acid in apples and apple pomace. Progress of Cryogenics & Isotopes Separation, 17(2), 53-62.

Gerszten, R. E., Garcia-Zepeda, E. A., Lim, Y. C., Yoshida, M., Ding, H. A., Gimbrone, M. A., Jr., Luster, A. D., Luscinskas, F. W., & Rosenzweig, A. 1999. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature, 398(6729), 718-723. doi:10.1038/19546

Gonzalez-Aparicio, M., & Alfaro, C. 2019. Influence of Interleukin-8 and Neutrophil Extracellular Trap (NET) Formation in the Tumor Microenvironment: Is There a Pathogenic Role? Journal of Immunology Research, 2019, 1-7. doi:10.1155/2019/6252138

Hermida, M. D. R., Malta, R., de S Santos, M. D. P. C., & Dos-Santos, W. L. C. 2017. Selecting the right gate to identify relevant cells for your assay: a study of thioglycollate-elicited peritoneal exudate cells in mice. BMC research notes, 10(1), 695-695. doi:10.1186/s13104-017-3019-5

Hopkin, S. J., Lewis, J. W., Krautter, F., Chimen, M., & McGettrick, H. M. 2019. Triggering the Resolution of Immune Mediated Inflammatory Diseases: Can Targeting Leukocyte Migration Be the Answer? Front. Pharmacol., 10(184), 1-9. doi:10.3389/fphar.2019.00184

Hossain, M. A., & Ismail, Z. 2013. Isolation and characterization of triterpenes from the leaves of Orthosiphon stamineus. Arabian Journal of Chemistry, 6(3), 295-298. doi:http://dx.doi.org/10.1016/j.arabjc.2010.10.009

Kashyap, D., Tuli, H. S., & Sharma, A. K. 2016. Ursolic acid (UA): A metabolite with promising therapeutic potential. Life Sci, 146, 201-213. doi:10.1016/j.lfs.2016.01.017

Muller, W. A. 2013. Getting Leukocytes to the Site of Inflammation. Veterinary pathology, 50(1), 7-22. doi:10.1177/0300985812469883

Shtein, R. M., Elner, S. G., Bian, Z.-M., & Elner, V. M. 2012. IL-8 and MCP Gene Expression and Production by LPS-Stimulated Human Corneal Stromal Cells. Int J Inflam, 2012, 1-4. doi:10.1155/2012/714704

Takahashi, M., Galligan, C., Tessarollo, L., & Yoshimura, T. 2009. Monocyte chemoattractant protein-1 (MCP-1), not MCP-3, is the primary chemokine required for monocyte recruitment in mouse peritonitis induced with thioglycollate or zymosan A. J Immunol, 183(5), 3463-3471. doi:10.4049/jimmunol.0802812

Tapondjou, L. A., Lontsi, D., Beibam Luc, S., Jongwon, C., Kyung-Tae, L., Hyun-Ju, J., & Hee-Juhn, P. J. A. o. P. R. 2003. In Vivo anti-nociceptive and anti-inflammatory effect of the two triterpenes, ursolic acid and 23-hydroxyursolic acid, fromcussonia bancoensis. 26(2), 143-146. doi:10.1007/bf02976660

Tesch, G. H. 2008. MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy. Am J Physiol Renal Physiol, 294(4), 697-701. doi:10.1152/ajprenal.00016.2008

Turner, M. D., Nedjai, B., Hurst, T., & Pennington, D. J. 2014. Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease. Biochim Biophys Acta, 1843(11), 2563-2582. doi:10.1016/j.bbamcr.2014.05.014

Vogl, S., Picker, P., Mihaly-Bison, J., Fakhrudin, N., Atanasov, A. G., Heiss, E. H., Wawrosch, C., Reznicek, G., Dirsch, V. M., Saukel, J., & Kopp, B. 2013. Ethnopharmacological in vitro studies on Austria's folk medicine-An unexplored lore in vitro anti-inflammatory activities of 71 Austrian traditional herbal drugs. J Ethnopharmacol, 149(3), 750-771. doi:10.1016/j.jep.2013.06.007

DOI: http://dx.doi.org/10.14499/indonesianjpharm30iss4pp252